EBF
EBF Open Symposium
EBF Barcelona
EBF 5th Open Meeting
Old Battles, New Horizons
Hesperia Tower Conference Centre
Barcelona, Spain
November 14-16, 2012
Open Symposium

Speakers

Application for oral contributions will be closed per September 10th 2012. Accepted speakers should sent in their presentation in powerpoint format to the open@europeanbioanalysisforum.eu email account before November 8th.

 

Confirmed speakers

  • Alex Muntendam (ABL B.V.)
  • Bart Remmerie (Janssen Research & Development)
  • Ben van Baar (on behalf of EBF)
  • Bernd Matthes (on behalf of the EBF topic team)
  • Brigitte Buscher (on behalf of the EBF Topic Team)
  • Carolyn Mailer (on behalf of the EBF topic team)
  • Catalin Doneanu (Waters)
  • Christoph Stove (Ghent University)
  • Clare Kingsley (Quotient Bioresearch)
  • David Jones (MHRA)
  • David Neville (Quotient Bioresearch)
  • Fabio Garofolo (Algorithme Pharma)
  • Franck Picard (Novartis)
  • Gregor Schaffar (Sandoz)
  • Hanneke van Assche (Abbott)
  • Hu Pei (PUMCH)
  • Huub Schellekens (Utrecht University)
  • Iris Vanwelkenhuysen (Janssen Research&Development)
  • James Munday (on behalf of the EBF topic team)
  • Jamie Sawyer (SQI Diagnostics, Inc.)
  • Joao Tavares (ANVISA)
  • John Smeraglia (Huntingdon Life Sciences)
  • Julie de Gagné (Novartis)
  • Karl Sköld (Denator AB)
  • Katja Heinig (on behalf of the EBF Topic Team)
  • Kenneth Fountain (Waters)
  • Kevin Bateman (Merck & Co)
  • Lester Taylor (Agilent Technologies)
  • Lieve Dillen (Janssen Research&Development)
  • Luc-Alain Savoy (SGS Life Science Services)
  • Magnus Knutsson (on behalf of the EBF Topic Team)
  • Mark Wrona (Waters / Vertex Pharmaceuticals)
  • Mauro Aiello (AB Sciex)
  • Melody Sauerborn (TNO Triskelion)
  • Michael Blackburn (Covance Laboratories Ltd)
  • Michael Spreadborough (AstraZeneca)
  • Michaela Golob (on behalf of GBC)
  • Nico van de Merbel  (PRA)
  • Nicolas Sabarth (Baxter)
  • Noriko Katori (National Institute of Health Sciences)
  • Peter van Amsterdam (on behalf of EBF)
  • Philip Timmerman (on behalf of EBF)
  • Pierre Picard (Phytronix Technologies Inc)
  • Richard Abbott (on behalf of EBF)
  • Richard Hucker (A4P Consulting Ltd)
  • Richard Kay (Quotient)
  • Rohan de Silva (University of London)
  • Ronald de Vries (on behalf of EBF)
  • Simon Szwandt (Thermo Fisher Scientific)
  • Stefan Kostense (Crucell Holland BV)
  • Stephanie Fischmann (Abbott)
  • Sue Sparrow (GlaxoSmithKline)
  • Sylvain Fleury (Mymetics Corporation)
  • Timothy Sangster (Charles River Laboratories)
  • Tom Verhaeghe (Janssen Research&Development)
  • Vera Hillewaert (Janssen Research&Development)
  • William van Dongen (TNO Triskelion)
  • Zoe Cobb (on behalf of EBF)